RARE - Ultragenyx Pharmaceutical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1471616
Avg. Estimate-1.67-1.65-7.13-5.95
Low Estimate-1.98-1.94-7.48-7.4
High Estimate-1.48-1.34-6.64-3.11
Year Ago EPS-1.73-1.82-3.97-7.13
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1481716
Avg. Estimate31.78M30.79M100.84M183.33M
Low Estimate27.93MN/A96.08M122.35M
High Estimate36M44.77M111M259M
Year Ago Sales16.26M18.17M51.49M100.84M
Sales Growth (year/est)95.40%69.40%95.80%81.80%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-1.79-1.74-1.7-1.68
EPS Actual-1.73-1.82-1.72-1.96
Difference0.06-0.08-0.02-0.28
Surprise %3.40%-4.60%-1.20%-16.70%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-1.67-1.65-7.13-5.95
7 Days Ago-1.67-1.65-7.13-5.89
30 Days Ago-1.68-1.62-7.14-5.83
60 Days Ago-1.68-1.6-7.16-5.71
90 Days Ago-1.62-1.55-6.82-5.26
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 Days21N/A1
Up Last 30 Days3132
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/A1N/A
Growth EstimatesRAREIndustrySectorS&P 500
Current Qtr.3.50%N/AN/A0.01
Next Qtr.9.30%N/AN/A0.05
Current Year-79.60%N/AN/A-0.02
Next Year16.50%N/AN/A0.14
Next 5 Years (per annum)17.20%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A